• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有硫醇作为金属β-内酰胺酶抑制剂的获批药物:对抗多重耐药细菌的策略

Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.

作者信息

Klingler Franca-M, Wichelhaus Thomas A, Frank Denia, Cuesta-Bernal Jenifer, El-Delik Jasmin, Müller H Florian, Sjuts Hanno, Göttig Stephan, Koenigs Arno, Pos Klaas M, Pogoryelov Denys, Proschak Ewgenij

机构信息

§Institute of Medical Microbiology and Infection Control, Paul-Ehrlich-Straße 40, 60596 Frankfurt, Germany.

出版信息

J Med Chem. 2015 Apr 23;58(8):3626-30. doi: 10.1021/jm501844d. Epub 2015 Apr 13.

DOI:10.1021/jm501844d
PMID:25815530
Abstract

Resistance to β-lactam antibiotics can be mediated by metallo-β-lactamase enzymes (MBLs). An MBL inhibitor could restore the effectiveness of β-lactams. We report on the evaluation of approved thiol-containing drugs as inhibitors of NDM-1, VIM-1, and IMP-7. Drugs were assessed by a novel assay using a purchasable fluorescent substrate and thermal shift. Best compounds were tested in antimicrobial susceptibility assay. Using these orthogonal screening methods, we identified drugs that restored the activity of imipenem.

摘要

对β-内酰胺类抗生素的耐药性可由金属β-内酰胺酶(MBL)介导。一种MBL抑制剂可以恢复β-内酰胺类药物的有效性。我们报告了对已批准的含硫醇药物作为NDM-1、VIM-1和IMP-7抑制剂的评估。通过使用可购买的荧光底物和热位移的新型测定法对药物进行评估。在抗菌药敏试验中测试了最佳化合物。使用这些正交筛选方法,我们鉴定出了能恢复亚胺培南活性的药物。

相似文献

1
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.含有硫醇作为金属β-内酰胺酶抑制剂的获批药物:对抗多重耐药细菌的策略
J Med Chem. 2015 Apr 23;58(8):3626-30. doi: 10.1021/jm501844d. Epub 2015 Apr 13.
2
Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.设计、合成及对金属β-内酰胺酶 IMP-1 具有高抑制活性的氨基酸衍生硫醇抑制剂的体外和生物学评价。
Eur J Med Chem. 2016 May 23;114:318-27. doi: 10.1016/j.ejmech.2016.03.017. Epub 2016 Mar 9.
3
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.具有抗抗生素耐药性金属β-内酰胺酶抑制作用的三唑抑制剂的结构研究。
Bioorg Med Chem. 2020 Aug 1;28(15):115598. doi: 10.1016/j.bmc.2020.115598. Epub 2020 Jun 18.
4
Progress toward inhibitors of metallo-β-lactamases.金属β-内酰胺酶抑制剂的研究进展。
Future Med Chem. 2017 May;9(7):673-691. doi: 10.4155/fmc-2017-0007. Epub 2017 May 15.
5
Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.基于TPA的锌螯合剂作为金属β-内酰胺酶抑制剂的合成及临床前评价
ACS Infect Dis. 2018 Sep 14;4(9):1407-1422. doi: 10.1021/acsinfecdis.8b00137. Epub 2018 Aug 2.
6
Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem.含硫醇的金属β-内酰胺酶抑制剂可使耐药革兰氏阴性菌对美罗培南重新敏感。
ACS Infect Dis. 2017 Oct 13;3(10):711-717. doi: 10.1021/acsinfecdis.7b00094. Epub 2017 Aug 28.
7
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.曲霉茉莉素A衍生物作为新型NDM-1抑制剂以克服抗生素耐药性的合成及生物学评价
Bioorg Med Chem. 2017 Oct 1;25(19):5133-5141. doi: 10.1016/j.bmc.2017.07.025. Epub 2017 Jul 14.
8
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.吡啶二羧酸衍生物作为新型德里金属β-内酰胺酶-1的抑制剂
J Med Chem. 2017 Sep 14;60(17):7267-7283. doi: 10.1021/acs.jmedchem.7b00407. Epub 2017 Aug 30.
9
Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors.整合基于巯基的金属β-内酰胺酶抑制剂中的铁载体亚结构。
Molecules. 2023 Feb 20;28(4):1984. doi: 10.3390/molecules28041984.
10
Cyclic Boronates Inhibit All Classes of β-Lactamases.环状硼酸酯可抑制所有类型的β-内酰胺酶。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02260-16. Print 2017 Apr.

引用本文的文献

1
Inhibition of metallo-β-lactamases in carbapenem resistant Gram negative bacilli by omeprazole and pantoprazole.奥美拉唑和泮托拉唑对耐碳青霉烯类革兰氏阴性杆菌金属β-内酰胺酶的抑制作用
Afr Health Sci. 2025 Jun;25(2):298-313. doi: 10.4314/ahs.v25i2.36.
2
Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors.可持续的朱利耶-乌吉反应及连续流动技术的应用催生了受卡托普利启发的新型广谱金属β-内酰胺酶抑制剂。
J Med Chem. 2025 Aug 28;68(16):17236-17257. doi: 10.1021/acs.jmedchem.5c00750. Epub 2025 Aug 15.
3
Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR .
将速尿重新用作抗多重耐药性金属β-内酰胺酶抑制剂
J Microbiol Biotechnol. 2025 Aug 7;35:e2506023. doi: 10.4014/jmb.2506.06023.
4
Small-molecule strategies to combat antibiotic resistance: mechanisms, modifications, and contemporary approaches.对抗抗生素耐药性的小分子策略:作用机制、修饰及当代方法
RSC Adv. 2025 Jul 14;15(30):24450-24474. doi: 10.1039/d5ra04047g. eCollection 2025 Jul 10.
5
Development and evaluation of 1,4,7-triazacyclononane-coupled β-lactams against metallo-β-lactamase producing bacteria.针对产金属β-内酰胺酶细菌的1,4,7-三氮杂环壬烷偶联β-内酰胺的研发与评估
RSC Adv. 2025 Jul 7;15(29):23427-23440. doi: 10.1039/d5ra01842k. eCollection 2025 Jul 4.
6
Harder than Metal: Challenging Antimicrobial Resistance with Metallo-β-lactamase Inhibitors.比金属还坚硬:用金属β-内酰胺酶抑制剂挑战抗菌药物耐药性
J Med Chem. 2025 Jun 12;68(11):10556-10576. doi: 10.1021/acs.jmedchem.5c00553. Epub 2025 May 30.
7
Approachable Synthetic Methodologies for Second-Generation -Lactamase Inhibitors: A Review.第二代β-内酰胺酶抑制剂的便捷合成方法:综述
Pharmaceuticals (Basel). 2024 Aug 23;17(9):1108. doi: 10.3390/ph17091108.
8
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides.一种基于氮杂苯并环丁烯反应性的新型生物响应性自牺牲间隔基,用于硫醇、酚类、胺类、磺酰胺或酰胺的控释。
Chem Sci. 2024 Apr 2;15(16):6168-6177. doi: 10.1039/d4sc01576b. eCollection 2024 Apr 24.
9
Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant .将泮托拉唑重新用作耐碳青霉烯类细菌中的金属β-内酰胺酶抑制剂。
Front Pharmacol. 2024 Mar 12;15:1366459. doi: 10.3389/fphar.2024.1366459. eCollection 2024.
10
Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases.阐明金属β-内酰胺酶抑制剂的关键化学部分,并确定目标金属β-内酰胺酶的优先级。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2318830. doi: 10.1080/14756366.2024.2318830. Epub 2024 Mar 15.